| Date | Title | Description |
| 15.07.2025 | Neuros Medical: $56 Million Series D Closed For Non-Opioid Pain Treatment | Neuros Medical, the maker of the FDA-approved Altius Direct Electrical Nerve Stimulation System for chronic post-amputation pain, announced an oversubscribed $56 million Series D financing round. The funding, led by EQT Life Sciences with p... |
| 14.07.2025 | Breakthrough Funding Fuels Amputee Pain Revolution | Neuros Medical secured $56 million in Series D funding. EQT Life Sciences led the investment round. This substantial capital accelerates the U.S. commercialization of Altius®, a groundbreaking system. Altius® is FDA-approved. It delivers no... |
| 09.07.2025 | Neuros Medical Raises $56M in Series D Funding | Neuros Medical, Inc., an Aliso Viejo, CA-based maker of the Altius® Direct Electrical Nerve Stimulation System, an FDA-approved, breakthrough non-opioid treatment for chronic post-amputation pain, raised $56m in Series D financing round.
Th... |
| 09.07.2025 | EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to commercialize FDA-approved treatment for post-amputation pain | EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to commercialize FDA-approved treatment for post-amputation pain
Wed, Jul 09, 2025 14:00 CET Report this content
Proceeds will be used to support U.S. commercializa... |
| 28.08.2024 | Neuros Medical Receives FDA Approval for the Altius® Direct Electrical Nerve Stimulation System | - |
| 12.01.2024 | Global Neurostimulation Devices Market to Reach Value of USD 12.33 Billion by 2030 | Skyquest Technology | - |
| 07.11.2023 | Neuros Medical Receives $25 Million From Trinity Capital | Trinity Capital – a leading provider of diversified financial solutions to growth-stage companies – recently announced the commitment of $25 million in growth capital to Neuros Medical, a bioelectric technology company focused on alleviatin... |
| 31.10.2023 | Trinity Capital Inc. Provides $25 Million Growth Capital to Neuros Medical, Inc. | - |
| 31.10.2023 | Neuros Medical Receives $25M Growth Capital | Neuros Medical, an Aliso Viejo, CA-based bioelectric technology company focused on alleviating chronic post-amputation pain and restoring quality of life, received $25M in Growth Capital.
The round was led by Trinity Capital (NASDAQ: TRIN).... |
| 31.10.2023 | Trinity Capital Inc. Provides $25 Million Growth Capital to Neuros Medical, Inc. | - |
| 15.09.2021 | Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain | |
| 29.06.2021 | Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System | |
| 09.01.2021 | Neuros Medical Raises $38.5M in Series BB Funding | Neuros Medical, Inc., a Willoughby Hills, OH-based medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, closed a Series BB financing totaling $38.5m.
The roun... |
| 08.01.2021 | Neuros Medical Raises $38.5M in Series BB Funding | California: Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 mil... |
| 07.01.2021 | Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain | |
| 07.01.2021 | Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain | |
| 07.01.2021 | Neuros Medical Raises $38.5M Series BB |
CLEVELAND, OH, Neuros Medical announced today the close of a Series BB financing totaling $38.5 million.
>> Click here for more funding data on Neuros Medical
>> To export Neuros Medical funding data to PDF and Excel, click ... |
| 07.01.2021 | Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain | - |
| 07.01.2021 | Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain | - |
| 02.09.2020 | Neurostimulation therapy startup NeuroPace closes $33M raise with extra $34M in debt financing | |
| 18.12.2019 | Can a wearable improve memory? Humm raises $2.6 million so consumers can find out | There’s an emerging body of research suggesting that electrical stimulation applied to the brain can help improve memory and cognitive function.
A recent study conducted by researchers from Boston University this year found that 70-year-old... |
| 29.07.2019 | You Are What You Think: How New Brain Care Advances Are Increasingly Person-Centered | It’s an exciting time in the field of brain science.
Researchers are working on new speech analysis tools for the diagnosis of Alzheimer’s.
New studies have shown that retina scans can be used to detect early signs of the disease, long befo... |
| 28.02.2019 | This Rare Disease Day, Let’s Do More | There are some 7,000 known rare diseases in the world today and they affect an estimated 25-30 million people in the United States alone.
This day, celebrated every year on February 28th, holds special significance to me because my six-year... |
| 14.08.2017 | iSelect Portfolio: Neuros Medical Closes $20 Million Funding Round | Neuros Medical, part of the iSelect healthcare portfolio since 2016, closed a $20 million Series AA financing round, led by U.S. Venture Partners and joined by iSelect, Boston Scientific, Aperture Venture Partners, Osage University Partners... |
| 10.08.2017 | Managing post-amputation pain with neurostimulation, Neuros Medical raises $20M | U.S. Venture Partners led the round with participation from Boston Scientific, Aperture Venture Partners, and Osage University Partners. JumpStart Inc., which also took part in the round, had previously invested in the business.
Jon Snyder,... |
| 08.08.2017 | Term Sheet — Tuesday, Aug. 8 | THE 17-YEAR SLOW BURN
Term Sheet typically focuses on one very specific kind of entrepreneurial success study: The kind where startup founders raise giant piles of venture capital to fuel hypergrowth, and then ride said hypergrowth to an IP... |
| 07.08.2017 | Neuros Medical Closed $20M in Venture Capital Financing | Neuros Medical, Inc., a Cleveland, OH-based neuromodulation company, closed a $20m Series AA venture capital funding.
The round was led by U.S. Venture Partners with participation from Boston Scientific, Aperture Venture Partners, Osage Uni... |
| 07.08.2017 | Osage University Partners Joins $20M Series AA for Neuros Medical | CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a neuromodulation company, announced today that it has closed a $20 million Series AA venture capital financing. U.S. Venture Partners led the financing, and was joined by Boston Scientific,... |
| 07.08.2017 | Neuros Medical Closes of $20M Series AA |
CLEVELAND, OH, Neuromodulation company, announced today that it has closed a $20 million Series AA venture capital financing.
>> Click here for more funding data on Neuros Medical
>> To export Neuros Medical funding data to ... |
| 07.08.2017 | Boston Scientific Joins $20M Series AA for Neuros Medical | CLEVELAND--(BUSINESS WIRE)--Neuros Medical, Inc., a neuromodulation company, announced today that it has closed a $20 million Series AA venture capital financing. U.S. Venture Partners led the financing, and was joined by Boston Scientific,... |
| 06.06.2016 | Jon Snyder: An American Entrepreneur | It was 2008, and Jon Snyder wasn’t happy.
He had spent 25 years building a career in medical device sales, specializing in products that used neurostimulation to help patients with a variety of conditions manage chronic pain. He had worked ... |
| 10.10.2013 | FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees | This milestone seems to be one on the path to success for the startup, which has seen funding from Boston Scientific (BSX), the U.S. Department of Defense, angels and venture capitalists for its technology.
According to the company’s websit... |
| 10.10.2013 | FDA OKs clinical trial for Neuros Medical’s pain implant | Neuros Medical Inc. said it received an investigational device exemption from the FDA to run a clinical trial of its Altrius implantable generator to treat chronic pain in amputees.
The Altius device, consisting of an electrode and a genera... |
| 18.07.2012 | Neuros Medical Raises $3.5M in Funding | Neuros Medical, Inc., a Cleveland, Ohio-based medical device company, has raised a $3.5m in funding.
The round was led by Boston Scientific and Glengary LLC, with participation from existing investors Case Tech Ventures, JumpStart Ventures,... |
| 18.07.2012 | Pain management: Boston Scientific joins Neuros Medical’s $3.5M funding round | Cleveland, OH- based Neuros Medical announced that it raised $3.5 million in its latest round of funding, with Boston Scientific (NYSE:BSX) and Glengary leading the investment.
Neuros recently received an investigational device exemption fr... |
| 24.05.2012 | Pain-relief neurostimulation company SPR gets $900K Ohio loan | SPR’s pain-relief system is initially aimed at reducing shoulder pain in patients who’ve suffered strokes, but the company views the device as a platform technology that eventually could treat pain in multiple areas of the body, CEO Maria B... |
| 08.02.2012 | Neurostimulation company Checkpoint raises $1.7M, looks to CE Mark | Checkpoint received U.S. Food and Drug Administration clearance to sell its device in late 2009. The company expects to receive the European equivalent, the CE Mark, within a few months.
The company’s handheld, disposable device, called the... |
| 06.07.2010 | Neuros Medical wins $1.5 million DoD grant | By Mary Vanac
Neuros Medical Inc. plans to double — maybe even triple — its employment over the coming year as it uses a $1.5 million U.S. Dept. of Defense grant to speed development of its neurostimulation device to block chronic pain.
The... |
| 02.07.2010 | Neuros Medical gets $1.5M defense award for pain-blocking device | The grant also will enable Neuros to hire between two and six product and clinical development staff members within 12 months. “We want to expand the team here to support the efforts going forward,” Snyder said. Neuros now employs three peo... |
| 02.07.2010 | Neuros Medical Receives $1.5M from the U.S. Department of Defense | Neuros Medical, Inc., a Cleveland, Ohio-based medical device company, has received a $1.5m Applied Research and Technology Development Award from the U.S. Department of Defense.
The award will aid technology development and human clinical r... |
| 03.03.2010 | Queen City Angels defy bad economy, invest in 8 health care companies | Akebia Therapeutics–Cincinnati biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease.
AssureRx–The Mason, Ohio company that provides bioinformatics to select the right drug ... |
| 01.02.2010 | Ohio Third Frontier stakeholders hope for nearly full funding for five-year extension | Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| 23.10.2009 | Neuros Medical Raises $1.8M Series A Financing Round | Cleveland, Ohio-based Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8m Series A round of financing led by the North Coast Angel Fund ... |
| - | Pain-relief neurostimulation company SPR gets $900K Ohio loan | Neurostimulation pain-relief device company SPR Therapeutics has been approved for a $900,000 loan from the state of Ohio.
The financing comes after Cleveland-area SPR earlier this year raised a $2.2 million series A round and announced tha... |
| - | Neurostimulation company Checkpoint raises $1.7M, looks to CE Mark | Neurostimulation company Checkpoint Surgical has raised a $1.7 million series B round of investment and expects to win European regulatory approval of its intraoperative device shortly.
The Cleveland-area company will use the new funding to... |
| - | Neuros Medical | “Neuros Medical, a Cleveland, Ohio based neuromodulation company, is focused on the development of proprietary therapies for unmet needs to patients worldwide. The Company’s patented platform technology, Electrical Nerve Block, is focused o... |
| - | Neuros Medical gets $1.5M defense award for pain-blocking device | Neuros Medical Inc. plans to double — maybe even triple — its employment over the coming year as it uses a $1.5 million U.S. Department of Defense grant to speed development of its neurostimulation device to block chronic pain.
The Willough... |
| - | Revolutionizing Job Hunting: How WeApply Puts You Ahead of the Pack
🔦 Spotlight
🤝 Venture Deals
✨Featured Event (11/9)✨
📅 LA Tech Calendar
📙 What We’re Reading
🤝 Venture Deals
🤝 Venture Deals
📅 LA Tec... | 🔦 Spotlight
If you've been job hunting recently, you've likely experienced the soul crushing challenge of navigating numerous job application platforms, often competing with hundreds of other applicants for a single position. WeApply’s data... |
| - | Neuros Medical | “Neuros Medical ” |
| - | Managing post-amputation pain with neurostimulation, Neuros Medical raises $20M | Neuros Medical Altius System
Neuros Medical is a medical device company harnessing neurostimulation to treat the chronic pain that lingers after limbs have been amputated. The Cleveland, Ohio-based business has closed a $20 million funding ... |
| - | Ohio Third Frontier stakeholders hope for nearly full funding for five-year extension | COLUMBUS, Ohio — Ask most people touched by Ohio Third Frontier whether the state’s largest economic development project ought to be renewed and you’ll get a resounding “Yes!” A tougher question: How much money should the state borrow to ex... |
| - | Queen City Angels defy bad economy, invest in 8 health care companies | Queen City Angels invested in seven life sciences companies and one health information technology company last year, according to its 2009 annual operating report (pdf).
The group of accredited investors finished the year with 12 investment... |
| - | FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees | Neuros Medical, a Cleveland-based medical device company, received an FDA investigational device exemption approval to begin a clinical study on its technology for intractable limb pain management for amputees. According to the company webs... |
